Joint Q2 Earnings Call Highlights

Joint NASDAQ: JYNT reported second-quarter results that reflected progress in its shift toward a capital-light, pure-play franchisor model, while management said patient retention improved to its highest level in more than five years.

MarketBeat • Aug 7, 2026

The Joint Corp. (JYNT) Q2 2026 Earnings Call Transcript

The Joint Corp. (JYNT) Q2 2026 Earnings Call Transcript

Seeking Alpha • Aug 7, 2026

The Joint Corp. (JYNT) Reports Q2 Loss, Tops Revenue Estimates

The Joint Corp. (JYNT) came out with a quarterly loss of $0.01 per share versus the Zacks Consensus Estimate of $0.11. This compares to a loss of $0.06 per share a year ago.

Zacks Investment Research • Aug 7, 2026

The Joint Chiropractic Earns Entrepreneur Recognition as a Premier Multi-Unit Franchise Investment

Top Brands for Multi-Unit Owners honor underscores continued momentum of nation's largest chiropractic franchise as experienced operators seek scalable healthcare investments SCOTTSDALE, Ariz., July 30, 2026 /PRNewswire/ -- The Joint Corp. (NASDAQ: JYNT), the nation's largest franchisor of chiropractic care through The Joint Chiropractic® network, has been recognized by Entrepreneur as one of its Top Brands for Multi-Unit Owners for 2026, further validating the brand's position as one of franchising's premier growth opportunities for experienced multi-unit and multi-brand investors.

PRNewsWire • Jul 30, 2026

The Joint Corp. to Report 2026 Second Quarter Results on Thursday, August 6 and Host Conference Call and Webcast

SCOTTSDALE, Ariz., July 23, 2026 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ: JYNT), the nation's largest franchisor of chiropractic care through The Joint Chiropractic ® network, announced it will report its 2026 second quarter financial results on Thursday, August 6, 2026, after the market close and host a conference call and simultaneous webcast at 5:00 p.m. ET that day. During the call, The Joint Corp. President and CEO Sanjiv Razdan and CFO Scott Bowman will review the Company's financial results and provide a business update, followed by a question-and-answer session.

GlobeNewsWire • Jul 23, 2026

The Joint Chiropractic Expands to 44th State with Opening of Rhode Island Clinic

Military spouse and military officer, multi-unit franchise owners Sarah and Yosef Perfido lead brand's entry into Rhode Island, highlighting continued growth of nation's largest chiropractic network SCOTTSDALE, Ariz., July 1, 2026 /PRNewswire/ -- The Joint Corp. (NASDAQ: JYNT), the nation's largest provider of chiropractic care through The Joint Chiropractic® network, today announced its official entry into Rhode Island, marking the brand's expansion to its 44th state with the grand opening of a new clinic in Warwick.

PRNewsWire • Jul 1, 2026

The Joint: Can Refranchising Unlock A Better Business?

The Joint Corp (JYNT) is transitioning to a pure asset-light franchisor model, aiming to boost margins and free cash flow. JYNT's refranchising strategy targets 13-15% net margins versus 5.7% LTM, with system-wide sales growth hinging on stabilization of core operations. Clinic count has declined as underperformers are closed, but early signs show improving member retention and patient metrics.

Seeking Alpha • May 26, 2026

The Joint Corp. Announces Milind Pant Elected as Director

- Global Executive with Extensive Digital and International Franchise-Led Growth Experience - SCOTTSDALE, Ariz., May 21, 2026 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ: JYNT), the nation's largest franchisor of chiropractic care through The Joint Chiropractic ® network, today announced the election of Milind Pant to its Board of Directors.

GlobeNewsWire • May 21, 2026

The Joint Corp. (JYNT) Q1 2026 Earnings Call Transcript

The Joint Corp. (JYNT) Q1 2026 Earnings Call Transcript

Seeking Alpha • May 11, 2026

Joint Q1 Earnings Call Highlights

The Joint NASDAQ: JYNT reported first-quarter 2026 results that management said reflect improving profitability as the company nears completion of its “Joint 2.0” transformation into a “pure-play franchisor.” President and CEO Sanjiv Razdan highlighted progress on refranchising, marketing initiatives aimed at improving patient trends, and early moves to position the business for what the company calls “Joint 3.0” beginning in 2027.

MarketBeat • May 8, 2026